Significance of REV7 Expression in p16‐Negative Oropharyngeal Squamous Cell Carcinoma

Kaho Momiyama,Shohei Tsutsumi,Yasutaka Sakurai,Sachiyo Mogi,Shunsuke Miyamoto,Yoshiki Murakumo,Taku Yamashita
DOI: https://doi.org/10.1002/hed.28015
2024-11-29
Head & Neck
Abstract:Background REV7 is a multifunctional protein involved in various biological processes, including DNA damage response. REV7 expression in human cancer cells influences sensitivity to DNA‐damaging agents, and its high expression level is reportedly associated with a poor prognosis in many carcinomas. However, the significance of REV7 expression in human papillomavirus 16–negative oropharyngeal squamous cell carcinoma (OPSCC) remains unclear. Methods REV7 expression was assessed by immunohistochemical analysis in 79 patients with HPV16‐negative OPSCC. We evaluated the effects of inhibiting REV7 expression on the proliferation and cisplatin sensitivity of FaDu, an HPV16‐negative pharyngeal SCC cell line. Results In patients with p16‐negative OPSCC, the high‐REV7‐expression group experienced significantly shorter overall survival than the low‐REV7‐expression group (p = 0.03) in the Cox regression analysis. Furthermore, REV7‐deficient FaDu cells showed suppressed cell growth and enhanced sensitivity to cisplatin in vitro. Conclusions REV7 expression is associated with a poor prognosis in HPV16‐negative OPSCC.
surgery,otorhinolaryngology
What problem does this paper attempt to address?